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Evidence is presented  for  the existence of at least 3 
different conformational states of the Neurospora 
plasma membrane H‘ATPase during its catalytic cycle. 
Incubation of isolated Neurospora plasma membrane 
vesicles with trypsin in the absence or presence of 
several different ATPase reaction cycle participants  or 
analogues thereof gives rise  to different ATPase deg- 
radation patterns depending upon the ligands em- 
ployed, as judged by  sodium  dodecyl sulfate-polyacryl- 
amide gel electrophoretic analyses. In the absence of 
any ligand, the ATPase (Mr - 105,000) is rapidly de- 
graded by trypsin  to small, undefined fragments with 
M, 5 10,000. In the presence of Mg’ and vanadate, a 
presumed transition state analogue of the aspartyl- 
phosphoryl-enzyme hydrolysis reaction, trypsin rap- 
idly degrades  the ATPase to M, - 95,000 with further 
degradation to an M, - 88,000 form occurring much 
more slowly, suggesting that during the enzyme de- 
phosphorylation reaction, the enzyme is in a confor- 
mational state significantly different than it is in when 
unliganded. In  the presence of MgADP, a nonhydrolyz- 
able competitive inhibitor of the ATPase, the enzyme is 
rapidly degraded to an M, - 88,000 form which is  re- 
sistant to further degradation, suggesting that sub- 
strate binding is also associated with a conformational 
change. Finally, in the presence of Mga’ plus another 
competitive, nonhydrolyzable ATP analogue, P,y-meth- 
ylene ATP, the ATPase is rapidly degraded to  an M ,  - 
95,000 form similar to  that which is produced in the 
presence of M8’ plus vanadate, and is then subse- 
quently degraded to an M, - 88,000 form similar to  that 
produced in  the presence of MgADP. The difference 
between the responses seen in the presence of  MgADP 
and P,y-methylene  ATP is suggested to lie in  the fact 
that, unlike ADP,  B,y-methylene ATP can participate in 
the formation of the transition state of the enzyme 
phosphorylation reaction even though it cannot phos- 
phorylate the enzyme.  On the basis of these findings, 
an outline of the sequence of events that occur during 
the catalytic cycle of the ATPase is presented. 
A substantial body of evidence has now accumulated which 
indicates that  the plasma membrane of the eukaryotic micro- 
organism Neurospora  crassa contains an electrogenic. proton- 
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translocating ATPase (I-3), the function of which  is to gen. 
erate  a protonmotive force that is used to drive the activc 
transport of a variety of different ions and molecules via 
chemiosmotic coupling devices known as porters (4-6). A 
similar situation  appears  to exist in yeast (7-10). Biochemical 
studies of the fungal plasma membrane ATPase in this labo. 
ratory  and several others have brought to light the realizatior 
that  the properties of this enzyme are  quite similar to those oj 
the more thoroughly studied Na+/K’-, Ca’+-, and H’/K’- 
translocating ATPases of animal cell membranes. Specifically, 
all of these ATPases have a major polypeptide chain with an 
M, - 100,000 (11-18), all are inhibited by vanadate (19-21), 
all form a phosphoryl-enzyme intermediate that has been 
identified as ,&aspartyl phosphate in at least 3 cases (22-24). 
and 3 of the 4 have been directly or indirectly shown to require 
a divalent cation in the enzyme dephosphorylation reaction 
(Refs. 25-27 and this communication). Such similarities have 
led several investigators to conclude that all of these ATPases 
may operate via a fundamentally similar mechanism (24, 
28-30). Along these lines, we have recently proposed  models 
which posit that  the generation of protons at  the active site is 
a  fundamental  feature of the molecular mechanisms of each 
of these enzymes (24, 30). 
A t  present, the primary goal in this laboratory is an  under- 
standing of the molecular mechanism of proton translocation 
catalyzed by the Neurospora plasma membrane ATPase. As 
pointed out before (11, 24), it is likely that what is learned 
about  this ATPase will contribute to our understanding of the 
molecular mechanism of ion-translocating ATPases in gen- 
eral. Pertinent to these ends, we have initiated studies de- 
signed to explore in detail the  rather likely possibility that 
conformational changes in the ATPase play an important role 
in the overall mechanism of transport catalysis. In a previous 
communication (31), experimental results were presented 
which  showed that inhibition of the Neurospora ATPase by 
the organic mercurial, parachloromercuribenzoate is sup- 
pressed by ATP and that MgATP protects the ATPase 
against inactivation by trypsin. These findings  suggested that 
the ATPase may undergo conformational changes during its 
catalytic cycle. It was subsequently found (11) that  the ATP- 
ase inhibitor vanadate markedly augments the protection by 
MgATP against tryptic inactivation, and that MgATP plus 
vanadate markedly improves the yield of active ATPase sol- 
ubilized  by lysolecithin (12). These findings strengthened the 
notion that significant conformational changes occur  during 
the catalytic cycle of the Neurospora plasma membrane ATP- 
ase and raised some intriguing possibilities as  to  the mecha- 
nism of vanadate inhibition of this enzyme. In this communi- 
cation, we describe in more detail the effects of vanadate and 
several other reaction cycle participants or analogues thereof 
on the  rate and  pattern of degradation of the Neurospora 
plasma membrane H’ATPase  by trypsin as judged by SDS- 
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PAGE‘ analyses. The results not only demonstrate that an 
enzyme conformational change occurs as  a result of substrate 
binding, but, in addition, clearly point to  a relationship be- 
tween additional enzyme conformational changes and the 
formation of the transition states of the enzyme phosphoryl- 
ation and dephosphorylation reactions. 
EXPERIMENTAL PROCEDURES 
Growth of Cetls and Isolation of Plasma Membrane Vesicles- 
Cells of the N. crassa sl strain were  grown, and plasma membrane 
vesicles were isolated as previously described (12), except that  the 
cells were grown under a  stream of sterile air (flow rate of approxi- 
mately 1.6 liters/min) which significantly increases cell and plasma 
membrane yields. 
Trypin Treatment-Plasma membrane vesicle pellets were resus- 
pended in ice-cold 0.01 M MES (pH 6.8 with Tris) containing 1 pg/ml 
of chymostatin to a concentration of  7-10 mg of protein/ml. A portion 
of this suspension containing 0.2 mg  of protein was then mixed on ice 
with 40 pI of 0.1 M MES  (pH 6.8 with Tris) containing 1 pg/ml of 
chymostatin, 20 p1 of 0.2 M solutions of the various nucleotides (pH 
6.8 with Tris), and/or 20 pl of 0.2 M solutions of a divalent cation salt, 
in a  total volume of 0.175 ml. The salt control contained 20 pl of 0.2 
M phosphoric acid (pH 6.8 with Tris)  and 27 pl of 0.2 M NazSOn in 
place of the nucleotide and divalent cation salt, respectively. When 
sodium vanadate was included during the trypsin treatment, it was 
added as 2 p1 of a 0.01 M solution (unbuffered and at  least 1 month 
old). The mixtures were preincubated for 3 min at 20 “C and the 
trypsin treatment was initiated by the addition of 25 pi of trypsin 
solution (2 mg/ml in 0.001 M HCl, 20 “ C ) .  After the desired times of 
incubation at  20 “C, the reactions were terminated by adding 0.1 ml 
of soybean trypsin inhibitor solution (2 mg/ml in 0.01 M MES,  pH 6.8 
with Tris)  and placing the resulting mixture on ice. The membranes 
were then pelleted by centrifugation (1800 X g, 15 min, 4 “C), freed of 
the  supernatant fluids, resuspended in 0.3 ml of ice-cold 0.01 M MES 
(pH 6.8 with Tris),  and pelleted again under the same conditions. 
After removing the  supernatant fluids, the membrane pellets were 
resuspended in 70 pl of ice-cold 0.01 M MES  (pH 6.8 with Tris), and 
aliquots were removed for ATPase assay, protein determination, and 
SDS-PAGE analysis. Zero time controls were obtained by adding a 
premixed solution of trypsin and soybean trypsin inhibitor to the 
various mixtures after the 3-min preincubation period and immedi- 
ately chilling the resulting suspensions. 
ATPase Assay-Assay mixtures contained 5 pl  of the various 
plasma membrane suspensions, 5 pl of 0.2 M ATP (pH 6.8 with Tris), 
5 pl of  0.2 M MgS04, 5 pl  of 0.1 M NaN3 (pH 6.8 with MES),  and 40 
CJ. of 0.1 M MES (pH 6.8 with Tris) in  a reaction volume of 100 pl. 
Reactions were initiated by the addition of the plasma membrane 
suspension, allowed to proceed at 30 OC for 10 rnin, and  terminated 
by the addition of 0.1 ml of 5% (w/v) sodium dodecyl sulfate solution. 
The inorganic phosphate  content in the entire 0.2 ml samples was 
then measured as described by Stanton (32). Reagent blanks were 
obtained by adding the SDS solution before the plasma membrane 
suspension. The specific activities of the ATPase in the various 
membrane preparations before trypsin treatment were in the range 
of 1.2 to 1.4 pmol of ATP hydrolyzed/mg of protein/min. 
Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis- 
SDS-PAGE was performed essentially as described (12) except that 
the double strength disaggregation buffer was 50 mM Tris  (pH 6.8 
with H,P04) containing 40% glycerol (w/v), 6% ,8-mercaptoethanol 
(v/v), 8% SDS (w/v), 2 r n ~  EDTA. Individual wells contained 50 pg 
of membrane protein. 
Other Methods-Protein was determined by the method of Lowry 
et al. (33) with bovine serum albumin as a  standard. The esterase 
activity of trypsin toward N-3-(Carboxypropionyl)-~-phenyIalanine- 
p-nitroanilide was determined by the spectrophotometric procedure 
of Erlanger et al. (34). 
Materials-Bovine s e w  albumin, MES, ATP ( T r j s  salt, low in 
vanadate), ADP (Tris  salt, low in vanadate), P,y-methyleneadenosine 
5‘-triphosphate (sodium salt), Trizma, a-methylmannoside, and chy- 
mostatin were from Sigma. Acrylmide, N,K-methylene-bisacryl- 
Mineola, NY. SDS-PAGE molecular weight standards  and electro- 
amide, and sodium dodecyl sulfate were from Gallard-Schlesinger, 
’ The abbreviations used are: SDS-PAGE, sodium dodecyl sulfate- 
polyacrylamide gel electrophoresis; MES,2-(N-morpholino)ethane- 
sulfonic acid. 
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FIG. 1. Effects of a variety of ATPase ligands on tryptic 
inactivation of the H+ATl’ase. Plasma membrane vesicles were 
treated with trypsin as described under “Experimental Procedures” 
in the presence of the following additions: o ” 0 ,  20 mM Tris- 
phosphate, 27 mM Na2SO4; u, 20 mM Tris-phosphate, 27 mM 
Na$304, 0.1 mM Na3V04; A-A, 20 mM MgS04, 20 mM Tris-ATP; 
A-A, 20 mM MgS04, 20 mM Tris-ATP, 0.1 mM NaZ1VO4; .“-1, 
20 mM MgS04, 20 mM Tris/Na P,y-methylene ATP; [)”-c3, 20 mM 
MgSO,, 20 mM Tris-ADP. Individual points are the average values 
obtained from duplicate ATPase assays plotted  as the percentage of 
the corresponding zero time controls. 
phoresis grade Tris  and glycine  were  from Bio-Rad. Sodium ortho- 
vanadate, analyzed as described by Stroobant  and Scarborough (61, 
was from Fisher. N-3-(Carboxypropionyl)-~-phenylalanine-p-nitroan- 
ilide was from Calbiochem. The trypsin preparation used in all of the 
described experiments was Worthington’s L-1-tosylamido-2-phenyl- 
ethyl chloromethyl ketone-treated trypsin. Soybean trypsin inhibitor 
was also from Worthington. All other reagents were of the purest 
commercially available grade. 
RESULTS 
Fig. 1 shows an expanded analysis of the phenomenon that 
we have previously termed differential trypsin sensitivity of 
the Neurospora plasma membrane ATPase (11). In this ex- 
periment, plasma membrane vesicles  were treated with tryp- 
sin for various times in the presence of simple salts or near 
saturating‘ levels of a variety of ATPase ligands, and then 
assayed for ATPase activity. The ATPase is rapidly inacti- 
vated by trypsin in the absence of any ligand and is inactivated 
more slowly in the presence of MgATP. Inactivation of the 
ATPase is even more markedly retarded in the presence of 
MgATP plus the ATPase inhibitor vanadate, but vanadate 
alone has  little effect. The ATPase is actually activated in the 
early stages of trypsin treatment in the presence of MgATP 
plus vanadate and certain other ligands. This effect is related 
to the nature of the tryptic cleavage products as will be 
discussed below. The effects of  two nonhydrolyzable3 compet- 
* Preliminary experiments in which the initial rates of ATP hy- 
drolysis were measured as  a function of the concentration of MgATP 
in the assay medium yielded straight line double reciprocal plots and 
an  apparent K ,  for MgATP of 2.6 mM. Similar experiments carried 
out in the presence or absence of several different concentrations of 
MgADP or Mg P,y-methylene ATP also yielded straight line double 
K,  values of 0.2 mM for MgADP and 3.7 mM for Mg P,y-methylene 
reciprocal plots with purely competitive characteristics and  apparent 
ATP. Vanadate inhibition is half-maximal around 1.6 p ~ .  
’ Neither Mg P,y-methylene ATP nor MgADP are hydrolyzed to a 
significant extent by the Neurospora plasma membrane ATPase 
(data not shown). 
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FIG. 2. Effects of divalent cations with or without vanadate 
on tryptic inactivation of the H+ATPase. Plasma membrane 
vesicles were treated with  trypsin  as  described under “Experimental 
Procedures” in the presence of the following additions: M, 27 
mM Na2S04; M, 20 mM MgS04; A-A, 20 mM CaC12; 
, 20 mM MgS04, 0.1 mM NasVOa; A-A, 20 mM CaClz, 0.1 
mM NaaV04.  Individual points are the average values  obtained from 
duplicate  ATPase  assays  plotted as the  percentage of the correspond- 
ing zero time controls. 
itive inhibitors of the  ATPase, MgADP, and Mg @,y-methyl- 
ene ATP, on the  rate of tryptic inactivation of the ATPase 
are also shown in Fig. 1. ATPase activity is rapidly lost in the 
presence of MgADP, but in the presence of Mg P,y-methylene 
ATP, there is a brief activation followed by a significantly 
slower rate of tryptic inactivation. Although the  data are not 
shown, none of the above nucleotides very markedly affects 
the  rate of tryptic degradation of the ATPase in the absence 
of a divalent cation. 
The remarkable effect of vanadate in retarding the  rate of 
tryptic inactivation of the ATPase in the presence of MgATP 
is further explored in Fig. 2. The vanadate effect does not 
require the presence of a nucleotide, but does require the 
presence of a divalent cation. Thus,  the ATPase is transitorily 
activated and effectively protected against tryptic inactivation 
in the presence of vanadate plus Mg2+ but is not significantly 
protected by Mg2+ alone. The results are quite similar when 
Ca2+ is used as  the divalent cation; however, some protection 
by Ca2+ alone is observed. The hydrolysis of the chromogenic 
substrate N-3(carboxypropionyl)-~-phenylalanine-p-nitroani- 
lide by trypsin is virtually unaffected by all of the above 
agents under experimental conditions identical with those in 
the above experiments which indicates that  the ligand  effects 
are indeed on the susceptibility of the ATPase to tryptic 
cleavage and not on the activity of the trypsin. 
The changes in the ATPase molecule during the trypsin 
treatments  are shown in Fig. 3. Entire gels are not shown  for 
reasons of space economy and to focus attention on the 
ATPase. As  we have shown  before,  only a few other membrane 
proteins are affected by trypsin under these experimental 
conditions and none of these displays differential trypsin 
sensitivity (11). In the absence of any ligand (Series A ) ,  trypsin 
rapidly degrades the ATPase as judged by its rapid disap- 
pearance from the M ,  - 105,000 area of the gel. Although not 
shown, the fragments produced are  either released from the 
membranes or are smaller than 10,000 daltons, because no 
identifiable new bands can be found in trypsin-treated mem- 
branes even when they are analyzed in SDS gels that resolve 
polypeptides down to M ,  - 10,000. The small amount of 
protein left in the M, - 105,000 region of the gels  is either an 
unrelated trypsin-resistant protein that co-migrates with the 
ATPase or ATPase molecules present in a small population 
of right-side-out vesicles. The ATPase is protected from tryp- 
tic degradation to some extent by MgATP but is largely 
destroyed by about 12 min (Fig. 3B). The two  most readily 
detected degradation forms of the ATPase molecule with M ,  - 95,000 and - 88,000 appear in stepwise fashion during the 
trypsin treatment. The faint band above the M, - 95,000 form 
of the ATPase is also a degradation product of the ATPase 
but is highly transitory and difficult to detect reproducibly. In 
fact, approximately 7000 daltons at the end (or ends) of the 
molecule are so sensitive to tryptic cleavage that partial 
removal of approximately 7000 daltons is often seen in the 
zero time controls which contain soybean trypsin inhibitor. 
Inclusion of vanadate with MgATP during the trypsin treat- 
ment (Fig. 3, Series C )  results in a  pattern markedly different 
from that seen with MgATP alone. The ATPase is rapidly 
degraded to  the M ,  - 95,000 form which is then extremely 
resistant to further degradation. On the other hand, in the 
presence of MgADP (Series D) ,  the ATPase is rapidly de- 
graded to the M ,  - 88,000 form which is also then quite 
resistant to  further degradation. The effects of P,y-methylene 
ATP (Series E )  are intermediate between MgATP plus van- 
adate  and MgADP, with a considerable survival time of the 
M ,  - 95,000 form relative to that seen in the presence of 
MgADP. The  pattern obtained from trypsin treatment of the 
membranes in the presence of Mg2+ plus vanadate (Series F) 
is similar to that seen with MgATP plus vanadate. The 
enzyme is rapidly degraded to the M ,  - 95,000 form  which  is 
then resistant to further degradation, albeit not quite as 
resistant as  it is in the presence of MgATP plus vanadate. 
With Mg2+ (Series G )  or vanadate (Series H) alone, protection 
is minimal. The results with Ca2+ plus vanadate (Series J) are 
similar to those obtained with Mg2+ plus vanadate. However, 
unlike  Mg2+ alone, Ca” alone (Series I) affords some protec- 
tion, particularly to  the M, - 88,000 form. Higher concentra- 
tions of Mg2+ (40 mM) elicit a response similar to  that seen 
with 20 mM Ca2+ (data not shown). 
DISCUSSION 
Comparison of the  data presented in  Figs. 1 and 2 with the 
tryptic degradation patterns shown  in  Fig. 3 provides a  rea- 
sonable explanation of the changes in ATPase activity that 
occur as a result of the treatment of the membranes with 
trypsin in the presence or absence of the various ligands. 
When the ATPase is degraded to small pieces, the activity is 
abolished. However, when the ATPase is present predomi- 
nantly as the M ,  - 95,000 form ( e g .  at 1 min of trypsin 
treatment in the presence of MgATP plus vanadate or  Mg2+ 
plus vanadate), the ATPase activity of the membranes is 
30-60% higher than it is in the control membranes. And  when 
the ATPase is present predominantly in the M ,  - 88,000 form 
(e.g. at 6-12 min of trypsin treatment in the presence of 
MgADP),  the activity of the membranes is  very  much  lower. 
The most reasonable interpretation of these results is that  the 
M ,  - 95,000 form is roughly 50% more active than  the M ,  - 
105,000 form, while the M ,  - 88,000 form is virtually inactive. 
The next point to be considered is whether or not the results 
presented here constitute sufficient evidence that  the 
H’ATPase does indeed undergo conformational changes dur- 
ing its catalytic cycle. In this regard, the only reasonable 
alternative explanation for the results we have obtained is 
that  the trypsin-sensitive sites  are physically shielded from 
trypsin by the binding of the various ligands.  Because the side 
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FIG. 3. SDS-PAGE analyses of the effects of trypsin on the 
H+ATPase in the presence or absence of several ATPase li- 
gands. Each horizontal series, designated A-J, shows the ATPase 
area of Coomassie blue-stained SDS-polyacrylamide gel analyses of 
membranes  obtained in the experiments of Figs. 1 and  2. In each case, 
chains of the amino acids responsible for the specificity of 
trypsin, i.e. lysine and arginine, are cationic at  pH 6.8 and the 
protective nucleotides and vanadate are anionic at  this pH, 
this possibility must be taken seriously. However, it is difficult 
to  put forward such  interactions as  the sole explanation of the 
protective effects of the nucleotides and  vanadate in  view  of 
the absolute  requirement for a divalent cation. The ability of 
Ca2' alone to partially protect the ATPase against tryptic 
degradation (Figs. 2 and 3) supports  this conclusion. Further- 
more, it is also worthwhile in this regard to mention again our 
recent observation (12) that vanadate markedly enhances the 
ability of MgATP to protect the ATPase against nonproteo- 
lysis-related inactivation during solubilization by lysolecithin, 
which suggests that MgATP plus vanadate help to hold the 
enzyme in a conformation that is more stable  than the unli- 
ganded one. It is also pertinent  to point out  that  the related 
enzymes, the Na'/K'- and Ca"-translocating ATPases of 
animal cells have both been shown to undergo substrate 
binding-dependent conformational changes by criteria  other 
than sensitivity to  tryptic degradation (e.g. Refs. 35-48). And 
finally, it should also be mentioned that  the occurrence of 
conformational changes upon the interactions of enzymes with 
their substrates is rapidly becoming recognized as  the rule 
rather  than  the exception (49-53). 
Assuming that  the results presented here and elsewhere (12, 
31) do indicate that  the H'ATPase undergoes conformational 
changes during its  catalytic cycle, we can now discuss the 
individual ligand effects as  they may relate to  the events that 
occur during the catalytic sequence of the H'ATPase. The 
effects of vanadate provide important clues in this regard. It 
is generally agreed that enzyme-catalyzed phosphoryl trans- 
fers usually proceed via in-line SNP-type nucleophilic dis- 
placement reactions which go through pentacoordinated in- 
termediates  or  transition states  that have trigonal bipyramidal 
geometry (54-58). The powerful inhibitory effects of ortho- 
vanadate on numerous phosphotransferase reactions at  rela- 
tively low concentrations (59) and its ability to form stable 
pentacovalent trigonal bipyramidal complexes (60) have led 
to  the general opinion that vanadate  acts as a  transition state 
analogue for the enzymes it inhibits (59). For enzymes which 
involve covalent phosphoryl-enzyme intermediates, there 
must be two transition  states,  one for enzyme phosphorylation 
and one for enzyme dephosphorylation, and for one enzyme 
of this type, the Na'/K'-translocating ATPase of animal cell 
plasma membranes, Cantley et ul. (61) have recently provided 
reasonable evidence that vanadate inhibits by acting as a 
transition state analogue of the enzyme dephosphorylation 
reaction. Because the Neurosporu plasma membrane 
H'ATPase is similar to  the (Na'/K')ATPase, and even more 
importantly, because the effects of vanadate on the resistance 
of the Neurospora ATPase to trypsin can be seen in the 
absence of any nucleotide, it is most reasonable to conclude 
that vanadate also inhibits  this enzyme by acting as a transi- 
tion state analogue of the enzyme dephosphorylation reaction. 
the well at  the extreme left contained control (untreated) membranes 
followed by membranes  treated  with  trypsin for the indicated times 
in the presence of the following  additions: A, 20 mM Tris-phosphate, 
27 mM Na2SOr; B, 20 mM MgSOr, 20 mM Tris-ATP c, 20 mM MgSOr, 
20 mM Tris-ATP, 0.1 mM Na:,VO,; 0, 20 mM MgSOr, 20 mM Tris- 
ADP; E, 20 mM MgSO4, 20 mM Tris/Na S,y-methylene ATP F, 20 
mM MgS04, 0.1 mM Na:lVOn; G, 20 mM MgSO.,; H, 20 mM Tris- 
phosphate, 27 mM Na2SOr, 0.1 mM Na:rVO,; I ,  20 mM CaC12; J,  20 mM 
CaC12, 0.1 mM Na:IVO4. The top, middle, and bottom arrows beside 
each series point to the M, - 105,000, M, - 95,000, and M, - 8 8 , 0 0 0  
regions of the gels, respectively. Certain series appear lighter than 
others because of variable destaining times. 
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As pointed out by Pauling (62) and elaborated upon by others 
(63-65), enzymes should have their greatest affinity for  the 
transition states of the reactions that they catalyze, from 
which it follows that  the complex between an enzyme and an 
analogue of the transition state of the reaction it catalyzes 
should be quite stable. Extending these considerations to  the 
results obtained here,  it  appears that  the H'ATPase  which, 
in the unliganded form, is extremely sensitive to degradation 
by trypsin, coalesces with Mg2+ (or Ca"') and vanadate to 
form a  stable complex, of relatively low free energy, with a 
polypeptide chain conformation different from that of the 
unliganded enzyme.  When the enzyme is in this conformation, 
only a piece of about 10,000 daltons can be removed by 
trypsin. Extrapolating to  the physiological ligands, it can be 
concluded that Mg2' is required for the enzyme dephosphor- 
ylation reaction and that during the enzyme dephosphoryla- 
tion reaction, the HCATPase is in a specific conformation 
which changes back to the unliganded conformation after 
hydrolysis of the phosphoryl-enzyme intermediate and the 
release of products. 
The comparative effects of MgADP and Mg P,y-methylene 
ATP on tryptic degradation of the ATPase also provide 
important information about the catalytic sequence. Both of 
these ligands are nonhydrolyzable competitive inhibitors of 
the  ATP hydrolysis reaction, yet their effects on tryptic deg- 
radation are significantly different. In the presence of MgADP, 
the ATPase is rapidly degraded to an M, - 88,000  form  with 
very little  intermediate appearance of the M, - 95,000 form. 
However, in the presence of  Mg P,y-methylene ATP, the 
pattern of enzyme degradation is much like that seen with 
Mg" plus vanadate, i.e. rapid production of the M,  - 95,000 
form and slower degradation of this form to  an M, - 88,000 
form. A comparison of the structures of ADP and P,y-meth- 
ylene ATP provides an explanation for this  apparent paradox. 
The most obvious  difference between the two  molecules is the 
presence in P,y-methylene ATP, of a y-phosphorus atom, and 
it is the y-phosphorus atom that undergoes nucleophilic attack 
by the enzyme-bound P-carboxyl group of aspartate during 
the formation of the transition state of the enzyme phospho- 
rylation reaction. Thus, we propose that  the most significant 
difference between the two nonhydrolyzable, competitive in- 
hibitors of the H'ATPase,  MgADP, and Mg P,y-methylene 
ATP, is that  the latter, because of the presence of a y-phos- 
phoryl moiety, can participate in the formation of the transi- 
tion state of the enzyme phosphorylation reaction, even 
though it cannot complete the transphosphorylation reaction 
due to  the stability of the methylene bridge. 
From the above considerations, an outline of the events 
which take place during the catalytic sequence of the Neuro- 
spora H+ATPase can be formulated. Before substrate binding, 
the ATPase is in a conformation that is rapidly degraded by 
trypsin to small pieces.  Upon  binding of  Mg2' and ATP, the 
enzyme undergoes a conformational change to  a form that can 
be degraded by trypsin to M ,  - 88,000. This is the form which 
predominates when the enzyme is saturated with MgADP. 
However, when a y-phosphate group is present in the sub- 
strate and the transition state for enzyme phosphorylation 
can form, the ATPase undergoes further conformational 
change to  a form which is degraded by trypsin to M ,  - 95,000. 
When the  substrate is Mg P,y-methylene ATP, an equilibrium 
is struck between the binding conformation of the enzyme 
(degradable to M, - 88,000) and the transition state confor- 
mation (degradable to M ,  - 95,000) with the latter predomi- 
nating. Thus, the M, - 95,000 form predominates in the early 
stages of the tryptic degradation, but it steadily gives way to 
the M, - 88,000 form. During the normal reaction cycle, i.e. 
when the  substrate is MgATP, the transition state next breaks 
down with the  resultant formation of the aspartyl-phosphoryl- 
enzyme intermediate. The events that occur next in the  re- 
action cycle are uncertain, but at some point ADP is released 
and the hydrolytic water molecule approaches the aspartyl 
phosphate phosphorus atom prior to the formation of the 
second transition state.  Whether or not the Mg"' stays with 
the enzyme is unclear, but evidence in support of such an idea 
has been presented for both  the Na+/K'- and Ca2'-translo- 
cating ATPases (25, 27). Additional conformational changes 
almost certainly occur as  the second transition state is ap- 
proached, and it seems quite likely that these changes have as 
their  counterparts  the traditional El  - P to E2-P conforma- 
tional changes of the Na+/K'- and Ca"-translocating ATP- 
ases (66,67). Upon the formation of the transition state of the 
phosphoryl-enzyme hydrolysis reaction, we again have infor- 
mation as  to  the  nature of the conformation of the enzyme. 
This is the conformation that is so markedly stabilized by 
binding with Mg" and vanadate. It is apparently quite similar 
to  the first transition  state conformation because the tryptic 
degradation profiles seen in the presence of  Mg P,y-methylene- 
ATP and Mg2+ plus vanadate are similar. The reaction se- 
quence concludes with the decomposition of the second tran- 
sition state  and  the production of enzyme-bound Pi.  Mg" and 
Pi then debind and the ATPase returns to its unliganded 
conformation, whereupon a new catalytic cycle  begins. 
In conclusion, the results presented in this communication 
provide evidence for conformational changes in the Neuro- 
spora plasma membrane H'ATPase related to  substrate bind- 
ing and the formation of the transition states of the enzyme 
phosphorylation and dephosphorylation reactions. Notably 
absent is any mention of the possible nature of the ion 
translocating events. This question will not be discussed here 
because none of the data presented bears directly upon it. 
However,  explicit notions as to how these results may relate 
to  the mechanisms of ion translocation catalyzed by all of the 
ATPases in the aspartyl-phosphoryl-enzyme intermediate 
family will be presented in a forthcoming communication (68). 
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